Navigation Links
FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia
Date:8/21/2008

cines and resources in the areas of bacterial infection and cardiovascular disease for healthcare providers and their patients in hospitals and other care facilities. For more information, visit http://www.ortho-mcneil.com.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., is part of Johnson & Johnson, the world's most broadly based producer of healthcare products. J&JPRD is headquartered in Raritan, NJ, and has facilities throughout Asia, Europe and the U.S. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas to address unmet medical needs worldwide.

FORWARD LOOKING STATEMENT

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 30, 2007. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov, http://www.jnj.com or on request from Johnson & Johnson. The Company does not u
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
2. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
3. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
4. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
5. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
6. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
7. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
8. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
9. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
10. Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
11. Go Healthy Initiates Additional Clinical Tests on Cholesterade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  The board of directors of VirtualScopics, Inc. ... clinical trial imaging solutions, today announced that James ... effective immediately.  Mr. Groff has held the role of ... VirtualScopics in January 2006 as an accounting manager and ... "When the board of VirtualScopics asked Jim to assume ...
(Date:8/21/2014)... 2014   Royal Philips (NYSE: ... has received 510(k) clearance from the U.S. Food ... application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through ... with pre-procedural, high-precision positioning to treat aortic stenosis ... is available as part of Philips IntelliSpace ...
(Date:8/21/2014)... MENLO PARK, Calif. , Aug. 21, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... ("Nat") Ricciardi to the Company,s newly expanded Board of ... now comprises eight directors, three of whom are independent. ... years of experience working with emerging growth companies. He ...
Breaking Medicine Technology:VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4
... LAKES, N.J., Oct. 4, 2011 BD (Becton, Dickinson and ... will conduct a live webcast of its fourth fiscal quarter ... November 2, 2011, at 8:00 a.m. (ET).  BD will issue ... The webcast of the conference call, along with ...
... LONDON, October 4, 2011 Taking place ... Grand, Berlin, Germany European Medical Device Technology ... executives in Europe,s medical device sector, today announced the ... for Medical Devices the only conference this year providing ...
Cached Medicine Technology:EMDT Launches New Specialist Conference on Managing Regulatory Change for Medical Devices 2
(Date:8/21/2014)... 2014 Top10BestSEOHosting.com has recently compared ... iPage ( http://www.top10bestseohosting.com/go/iPage/ ) is one of the ... , The manager of Top10BestSEOHosting.com states, “It is ... Actually, these companies have outperformed their competitors on ... People can get the best web hosting at ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 An increasing ... a taxpayer that their federal tax payment is being ... appears to come from the IRS, “tax@irs.gov”, it’s actually ... provide personal and financial information. , While similar scams ... an uptick in phishing activity is occurring right now. ...
(Date:8/21/2014)... Patients with advanced laryngeal cancer appear to have ... than nonsurgical chemoradiation. , Author: Uchechukwu C. Megwalu, ... at Mount Sinai, New York, and colleagues. , ... cancer are diagnosed each year and squamous cell ... tumors. Prior to 1991, total surgical removal of ...
(Date:8/21/2014)... at a low or very low birth weight may ... diabetes. The findings, which appear in Diabetes Care ... type 2 diabetes in African American populations, which has ... from Boston University,s Slone Epidemiology Center followed more than ... over the course of 16 years, analyzing characteristics such ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Among seniors, dimming vision ... The study involved more than 2,500 people, aged 65 to ... and again two, six and eight years later. Vision ... person,s risk of death during the study period, the researchers ... researchers led by Sharon Christ of Purdue University in West ...
Breaking Medicine News(10 mins):Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2
... Service Helps Providers Better Partner with Patients in ... Deepening its commitment to empowering patients and ... & Associates, LLC, a firm of strategic healthcare ... has established a new, first-of-its-kind service called Patient ...
... New Orleans, LA Xiaoming, Xu, PhD, Associate ... Health Sciences Center New Orleans School of Dentistry, ... of $1.77 million over four years by the ... fluoride-releasing, and bioactive dental materials including dental composites, ...
... Fla.--A new blood test used in combination with a ... of prostate cancer diagnosis, and could eliminate tens of ... according to a study led by researchers at Dana-Farber ... American Society of Clinical Oncology in Orlando, Fla., William ...
... Estimator(TM) Gives Patients Visibility into Treatment Costs before ... with the high number of uninsured and underinsured ... in consumer-driven health plans, such as Health Savings ... their own healthcare costs. As a result, hospitals ...
... Now, no matter when a patient with the ... a Spanish-speaking representative is available to help. Insulet Corporation ... insulin pump technology with its OmniPod System, has expanded ... a day, seven days a week."Managing diabetes is a ...
... NEW YORK, May 28 A new history of shock ... They Don,t Want You to Know About Shock Treatment" ( ... the Food and Drug Administration,s failure to investigate the devices ... is timely due to the FDA,s recent decision to call ...
Cached Medicine News:Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 2Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 3Health News:Gullapalli & Associates Launches First-of-Its-Kind Patient Centered CME(TM) (PCCME(TM)) Service, Names Dora Ochsenbein Manager of Educational Planning 4Health News:New blood test greatly reduces false-positives in prostate cancer screening 2Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 2Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 3Health News:Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates 4Health News:Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock 2Health News:Spanish-Speaking OmniPod Customer Support Now Available Around-the-Clock 3Health News:New Book Highlights Human Cost of FDA's Failure to Investigate Medical Devices 2
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Blunt tipped forceps with entire interior surface of tip serrated. For general purpose membrane grasping (coarse membranes)....
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps : Eckardt End & Side Gripping Forceps...
Medicine Products: